Pharmaceuticals and Biotech | Media Room

Press Release Nov 18, 2020

Danone Nutricia Research and the Rome Foundation Join Forces to Investigate Gut Discomfort Through Unprecedented Study in US, UK and Mexico

Press Release Nov 18, 2020

KND Labs Announces New Division, KND Biopharma

KND Biopharma is an enterprise-level supplier and best-in-class producer of hemp-derived Active Pharmaceutical Ingredients (API) Read More

Press Release Nov 18, 2020

John Poulos Appointed to Memgen's Board of Directors

Press Release Nov 17, 2020

Foxx Life Sciences Announces Opening of New Asia Headquarters in India

Press Release Nov 17, 2020

Enalare Therapeutics Appoints 3 New Members to Its Board of Directors

The addition of Gino Santini, Bob Yedid, and Joe Petko Significantly Expands Company's Pharmaceutical and Financial Markets Experience and Capabilities Read More

Press Release Nov 12, 2020

Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB

New research collaboration and licensing agreement with Lacerta provides UCB access to a novel gene therapy program and proprietary AAV capsids Read More

Press Release Nov 12, 2020

Epygenix Therapeutics Announces First Patient Successfully Dosed in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100

Press Release Nov 11, 2020

PharmaNest Announces New Pre-Clinical NASH and Clinical Liver Cancer Data to Be Presented at the AASLD | the Liver Meeting Digital ExperienceTM (TLMdX) 2020

New digital image analysis data of stained tissues and biopsies with FibroNest is presented for the continuous assessment of the severity and regression of Fibrosis in human in-vitro 3D NASH Spheroid models and for the automated classification of post-transplant patients in F4 Fibrosis Stage with and without Hepatocellular carcinoma (HCC) at the Liver Meeting Digital Experience 2020 Read More

Press Release Nov 10, 2020

Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership

Press Release Nov 9, 2020

Lohxa LLC Issues Voluntary Nationwide Recall of Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

Press Release Nov 9, 2020

Enalare Therapeutics Appoints Daniel Motto as Chief Business Officer

Press Release Nov 6, 2020

Aalto Bio Reagents Launches First nCOV Nucleocapsid Based Monoclonal Antibody for Antigen Testing for COVID 19

Aalto Bio Reagents Launches First Monoclonal Antibody Against SARS-CoV-2 Nucleocapsid Protein. Read More

Press Release Nov 4, 2020

Jubilant Radiopharma and SOFIE Biosciences Ink Strategic Partnership Deal to Further Advance the Field of Molecular Imaging & Therapeutics

Press Release Nov 2, 2020

Continued Growth at MedEvoke Offers New Benefits to Clients

Where tactical precision, creative thinking, expert analysis, and passion provide quality outcomes. Read More

Press Release Oct 30, 2020

Enalare Therapeutics Appoints Herm Cukier as Executive Chairman, President, and CEO

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory conditions, announced today that it has appointed biopharma industry veteran Herm Cukier as its Executive Chairman of the Board, President, and Chief Executive Officer. Read More

Press Release Oct 29, 2020

AnaBios and Orion Publish Scientific Article Describing Novel Cardiac Compound

Press Release Oct 29, 2020

Introducing HardyCHROM Burkholderia Cepacia Complex for USP <60>

The newest product in Hardy Diagnostics' line of chromogenic, selective and differential culture media Read More

Press Release Oct 28, 2020

New England Peptide Receives Massachusetts Manufacturer of the Year Award

5th Annual Massachusetts Manufacturer of the Year Read More

Press Release Oct 27, 2020

Enterin Announces Appointment of VP, Head Of Medical And Clinical Development

Press Release Oct 22, 2020

Helix Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares

Press Release Oct 21, 2020

VMS BioMarketing Named to Best Small & Medium Workplaces List for 2020 by FORTUNE® Magazine and Great Place to Work®

Press Release Oct 20, 2020

Deborah Moorad-Watts Appointed Chief Executive Officer of Nature Technology Corporation (NTC)

Press Release Oct 20, 2020

C3® International, Inc. Commissions Industrial-Scale, Custom Extraction Laboratory From ENTEXS Corporation

Press Release Oct 19, 2020

Helix Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

Press Release Oct 16, 2020

Enterin Announces Appointment of New CEO

Press Release Oct 14, 2020

Tevogen Bio Announces IND Submitted to FDA for Clinical Trials of T Cell Treatment for COVID-19

Press Release Oct 13, 2020

Not a Normal 20 Year Anniversary for Cmed

Press Release Oct 9, 2020

Stellar Speakers to Make Targeting Metabesity 2020 One of the Most Important Healthy Longevity Conferences of the Year

Congresswoman Donna Shalala to join leading scientists, developers, regulators, and policy/business decision-makers who are seeking to accelerate translation of major scientific discoveries into products that slow the aging process and onset of major chronic diseases. Read More

Press Release Oct 8, 2020

Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua's Copeland Park

Press Release Oct 8, 2020

Philogen Announces Publication of Malignant Brain Tumor Study Results in Science Translational Medicine

(i) Study shows Philogen's proprietary immunocytokines are effective treatment for brain tumors. (ii) Early promising findings from Philogen's Phase I/II study investigating the safety and efficacy of L19TNF monotherapy in patients with glioblastoma. (iii) Philogen's proprietary cancer treatment found to be safe and well-tolerated. Read More

Press Release Oct 7, 2020

Cmed Opens Subsidiary in France

Press Release Oct 6, 2020

GB Sciences Files Provisional Patent Application for the Treatment of Chronic Inflammation Utilizing Its Novel Cannabinoid Containing Complex Mixtures (CCCM)

This marks the 11th U.S. provisional patent application filed by GBS covering the use of CCCM™ for unique medical disorders, creating an IP portfolio that contains formulas for up to 50 potential therapeutic indications. Read More

Press Release Oct 6, 2020

CapsCanada® Calling for the Return of Pharma Manufacturing to the U.S.

COVID-19 is highlighting the U.S.' reliance on foreign pharmaceuticals: CapsCanada® presents solutions to the situation Read More

Press Release Oct 2, 2020

Epygenix Therapeutics Announces First Patient Enrolled in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100

Press Release Oct 1, 2020

Simbec-Orion and Oncodistinct Network Agreement to Strengthen Early Phase Oncology Research

Providing oncology drug developers with the successful delivery of early phase oncology studies Read More

Press Release Oct 1, 2020

PTP Recognized as Company of the Year, AWS Consulting/Services Companies, by CIO Applications

With the AWS Partner Network designations of Advanced Consulting and the Life Sciences Competency, PTP continues to develop its cloud migration, management, optimization and security services to help its customers reach their business goals. Read More

Press Release Sep 29, 2020

Royal Biologics Completes 100th Cyro Cord™ Case, Successfully Enrolls First Patient Into Diabetic Foot Ulcer Study

Press Release Sep 28, 2020

GeneTex SARS-CoV-2 Nucleocapsid and Spike Antibodies Independently Validated by HistoWiz for Immunohistochemistry

Press Release Sep 22, 2020

SiO2 and Canadian Government Enter Into Agreement for Supply of Hybrid Vials and Syringes for COVID-19 Vaccines

Press Release Sep 18, 2020

P23 Labs Announces P23 Respiratory ONE

When anyone who has COVID-19 symptoms tests negative for COVID-19, this is the test they need Read More

Press Release Sep 17, 2020

IVIEW Collaboration With Dr. Amin Javer at St. Paul's Hospital and Sinus Centre, Canada to Study Povidone Iodine Formulations Including IVIEW-1503, a Long-Lasting Povidone Iodine Nasal Spray for the Treatment of COVID-19

Press Release Sep 17, 2020

Epygenix Therapeutics Initiates Phase 2 Study for Dravet Syndrome With EPX-100

Press Release Sep 16, 2020

Acellular-Convalescent Plasma (A-CP) and New Technologies Introduced by Regen Lab®

Press Release Sep 9, 2020

Almac Clinical Technologies Named Leader in Key Industry Report

IXRS®3 selected as preferred IRT application on flexibility, quality, and project management Read More

Press Release Sep 9, 2020

Inherent Biosciences Wins $256K NSF Grant to Predict COVID-19 Infection Severity and Treatment Response

Press Release Sep 3, 2020

Fixx Pharmaceuticals Says Human Embryo Gene Editing Should Wait

Fixx Pharmaceuticals founder, Jesse John Francis Clark, responds to recent report stating that human embryo gene editing isn't safe, yet. Read More

Press Release Sep 2, 2020

Cambridge Isotope Laboratories, Inc. Expands Benzene and Bromobenzene Capacities to Meet Customer Demands

Press Release Sep 1, 2020

Royal Biologics Announces the Acquisition of FIBRINET

The acquisition of the FIBRINET system adds new novel technology to Royal Biologics' growing portfolio of Autologous Live Cell solutions Read More

Press Release Sep 1, 2020

GEN inCode Announces Completion of £3M Institutional Foundation Fundraise

Press Release Aug 31, 2020

Eckert & Ziegler's GalliaPharm® to Be Distributed by Jubilant RadiopharmaTM in Canada

Jubilant Radiopharma to distribute Eckert & Ziegler's proprietary generator GalliaPharm® in Canada to meet the growing demand of this unique product. Read More

Press Release Aug 30, 2020

USDA Gives Thumbs Up to Primate Center Alpha Genesis

Important research continues without interruption Read More

Press Release Aug 29, 2020

Primate CRO Alpha Genesis Continues COVID-19 Vaccine Development Efforts

Research continues with new testing capabilities. Read More

Press Release Aug 28, 2020

MedEvoke Promotes Shauna Aherne to Executive Vice President

Press Release Aug 28, 2020

LEADING NIH EXPERT on GNE MYOPATHY JOINS the NEUROMUSCULAR DISEASE FOUNDATION (NDF)

Dr. Nuria Carrillo joins the Staff at Top Patient Advocacy organization for GNE Myopathy Read More

Press Release Aug 28, 2020

TIKOMED Granted Orphan Medicinal Drug Designation for ILB® for the Treatment of Amyotrophic Lateral Sclerosis by the European Commission

Press Release Aug 27, 2020

Blinktbi Accelerates Expansion of EyeStat Platform Technology With Appointment of Jeff Riley as Chief Executive Officer

Mr. Riley to Lead Corporate Development Efforts as Company Targets New Clinical Applications for its Proprietary, FDA-Cleared Blink Reflex Technology Read More

Press Release Aug 27, 2020

Fixx Pharmaceuticals Wants to Dominate Hemophilia Market With Gene Editing

Press Release Aug 27, 2020

Meenta Launches World's Largest COVID-19 Testing Platform

Online Marketplace Offers Businesses, Universities and Manufacturers Immediate Access to More Than 100 Labs and 500,000 Tests a Week Read More

Press Release Aug 26, 2020

Hemophiliac Launches Biotechnology Company to Develop a Cure for Hemophilia

Fixx Pharmaceuticals was founded by Jesse John Francis Clark - a man dedicated to improving the lives of those suffering from bleeding disorders. Read More

Press Release Aug 26, 2020

GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM™)

Based on data from a two-year study, GBS's CCCM were designed for the treatment of Cytokine Storm Syndromes, while preserving anti-viral immune reactions Read More